We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Silence Therapeutics Plc | LSE:SLN | London | Ordinary Share | GB00B9GTXM62 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 535.00 | 521.00 | 524.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
07/1/2014 22:34 | this could be a huge threat to SLN | looky | |
04/1/2014 08:24 | Happy New Year Gowboy and everyone else. Not sure why the drop and climb back up, but not untypical for this stock as we all know. Still, you never know it might just be the final chapter this year and we can all go away wiser, if not richer (for some of us). Eagle | ukeagle2aus | |
02/1/2014 09:46 | Happy New year all..... seems interest is back. ..... Back to £3? | gowboy | |
14/12/2013 20:05 | Shows u what sort of money is around Roche $1B funding deal with Immatics. SOmething like this would be cool for SLN | billthebank | |
04/12/2013 13:50 | Back in again after an absence of nearly a year. If Richard Griffiths thinks it's worth topping up his already significant stake at these levels, then that's good enough for me! Just 1500 at 207p to start with. | callumross | |
24/11/2013 07:36 | Interesting article in MIT Technology Review, Oct/Nov 2013.....pharmaco-ec The ethics of this is a good question for the moral maze.... | multibagger | |
22/11/2013 12:40 | Waterloo sounds like my current strategy! LOL, but still cannot work out where these will end up. Been so so long into these I'm a bit blind to what I exactly want in the end! Good luck all and Rik I'd like to say stay patient but that might be a bit patronising. GLA | ukeagle2aus | |
22/11/2013 11:04 | It's the lack of focus that bothers me. Very scatter gun approach. Throw money in every direction and hope something lands. | waterloo01 | |
22/11/2013 10:49 | Sounds promising but disappointing that all we saw immediately after it was a shed load of selling. The conspiracy theorists might argue that this was engineered to enable them to get in lower but not sure I buy that one. You need patience and then some with this company.. | rikky72 | |
21/11/2013 23:18 | Silence Therapeutics to Validate Endothelial RNAi Knockdown in Man | algernon2 | |
21/11/2013 13:23 | Did anyone find the Investor Day presentation (avail after 5pm on the day)? I've looked everywhere on their website.... But not dismissing me being a bit daft!!! | pwilk47490 | |
21/11/2013 13:19 | Wondering if it is the ex NOMAD selling i.e. Singer's now they have lost the brokership.......... | benson384 | |
21/11/2013 12:20 | Disappointing to see this sell off to near £2 after the recent rally to almost £3. Clinical trial news was welcome but underwhelming... positive results, new partnerships and milestone payments are what's really needed here.. | rikky72 | |
18/11/2013 15:42 | Go for it! | mdw1 | |
18/11/2013 14:11 | A new NOMAD should get story out and about, yet again....be interesting to see how many ex posters attend and post after the presentation. Seeing we got this right shall we target £3.50 now !!!!!?? | benson384 | |
18/11/2013 14:04 | We called this right Benson, news ahead of investor presentation. Presume others have exited or so bored they don't bother to look anymore? Anyway, onwards and upwards! | mdw1 | |
18/11/2013 13:56 | Sums this up...........good news, board changes, new test etc., and no comments even though price going north... | benson384 | |
14/11/2013 13:08 | Hi Eagle...a lots changed since the heady days of £2 plus when I was £20k in profit and should have sold lol. There used to be some good banter on here. Hows Auz...have you heard from Geoff? :0) | barefoot1 | |
13/11/2013 07:23 | It's getting kinda lonely on here these days! Had some annuities mature recently and have to say I've gone safe with reinvestment in Lloyd's, Barclays, Tesco - not like me, but at my stage of life the risks have to be reigned in a bit. Still have a major lump in these, but would let them go at a loss and move on if there was a reasonable tick up soon! Eag | ukeagle2aus | |
04/11/2013 11:17 | Eagle to Geoff! Where are you my friend? The O's are cooking on gas, hopefully you're getting there with your family to see it all unfold! :-) eagle | ukeagle2aus | |
28/10/2013 20:29 | A couple of decent buys after the close; maybe ahead of news; who knows? | mdw1 | |
24/10/2013 14:10 | You may well be right benson; what would be the point of an investor conference if there was nothing new to talk about and discuss............. | mdw1 | |
24/10/2013 11:50 | The investor conference on 18th November I guess is the reason why the fall over last few days. i.e. there will be no material new information presented.... Unless of course it is announced before the conference ? !!! | benson384 | |
23/10/2013 22:47 | Does anyone know if any news is due in the next 3-6 months? I can't really glean the likelihood of this, and from what source it may come, from reading through the last results. | rikky72 | |
18/10/2013 10:47 | That would be great but I really can't see it happening though. More than happy to be proved wrong though. It worries me that we're not really hearing about other developments besides ATU027 as well. If ATU027 works it's obviously a game changer but they need to show solid progress on other fronts to diversify their risk. It would also provide sorely needed newsflow. | rikky72 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions